Search

AB Volvo has hired Jan-Eric Sundgren, the president of Chalmers University of Technology, to become a member of its executive committee, overseeing the Swedish carmaker's ties with public authorities and academia.

IP2IPO Group, which specialises in commercialising university technology, has made an exclusive 25-year deal with the University of Bristol to form spin-out companies from the university. Analysts greeted the deal as a boost for the company.

Microsoft is to open more research centres in Europe, in a move to step up its research collaboration and boost students' interest in the technology field.

"Anything that won't sell, I don't want to invent. Its sale is proof of utility, and utility is success." Thomas A. Edison (1847-1931).

A new Munich-based company that says its patented technologies can reduce household water consumption by 90 per cent on average is looking for more investment.

A British pharmaceutical distributor, Beckpharma Ltd., said it licensed two Cuban healthcare products to sell in Europe as part of a broader effort for trade links.

On the glut of patenting, BASF's rising research budget, football fever in the Commons, and other insights into R&D management

Some strange new ways of raising money are starting to emerge - but would-be borrowers and lenders are still making sense of them.

Better, brighter, faster – that's where photonic lasers are trying to take us. A lay guide to the technology.

With licensing and collaboration now the lifeblood of the drug industry, the annual BIO-Europe get-together was focused on partnering. Nuala Moran was there.

New regulations on the registration and testing of chemicals could have some problematic knock-on effects on European R&D – but they could also bring some lucrative work the way of contract research organisations.

A politician's gaffe highlights the gender gap in science. Political action, not talk, is what's needed to close it.

Scientists are moving around as never before. And, argues Jean Guinet from the OECD, that’s not necessarily a bad thing.

A new proposal from the European Investment Fund seeks to accelerate the success of European technology transfer projects. A noble idea, says Mary Lisbeth D'Amico in her fortnightly column, but no one has yet stepped up to foot the bill.

OrthoMimetics, the first technology spin-out from the Cambridge-MIT Institute, Cambridge, UK, has begun its search for initial funding.